IARC, Lalla Salma Foundation report addresses barriers to cervical cancer screening in Benin, Côte d’Ivoire, Senegal

KU Cancer Center deploys new mobile cancer screening bus

The University of Kansas Cancer Center and its outreach network, the Masonic Cancer Alliance, announced a new effort to provide cancer screening throughout the cancer center’s catchment area. Known as HOPE on Wheels: Health, Outreach, Prevention, and Education, a 42-foot bus will help ensure that geography isn’t a barrier to detecting cancers earlier.

March 20, 2026

Vol.52 No.11

Clinical Roundup

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Clinical, real-world data reaffirming the long-term effectiveness of Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and Gardasil (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases will be presented at the EUROGIN International Multidisciplinary HPV Congress 2026 in Vienna, Austria, March 18-21.

March 20, 2026

Vol.52 No.11

Clinical Roundup

Positive topline results announced from phase I study of Lymphir + pembrolizumab in r/r gynecologic cancers

Citius Oncology announced positive topline results from a completed investigator‑initiated phase I clinical trial conducted by University of Pittsburgh investigators. This study evaluated the direct T-regulatory cell depletion activity of Lymphir (denileukin diftitox‑cxdl) in combination with the PD-1 immune checkpoint inhibitor pembrolizumab (Keytruda) in patients with recurrent or refractory gynecologic cancers, including ovarian and endometrial malignancies.

March 13, 2026

Vol.52 No.10

Podcast The Directors

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

“We’ve always argued that money comes and goes, but if you lose a generation of scientists—you can’t buy them back,” said Kelvin Lee, director of the Indiana University Simon Comprehensive Cancer Center.

February 27, 2026

Vol.52 No.08

By Claire Marie Porter and Paul Goldberg

Clinical Roundup

HPV cancer vaccine slows tumor growth, extends survival in animal models

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure.

February 13, 2026

Vol.52 No.06

Podcast

With five-year cancer survival at an all-time high, does this mean people are living longer?

“It's really, really important that every year since 1991, cancer mortality has dropped by a little bit, and it did again!” said Paul Goldberg, editor and publisher of The Cancer Letter. “Now, mortality is a good metric, age-adjusted mortality. As far as survival, well, that's not so good.”

January 21, 2026

IARC, Lalla Salma Foundation report addresses barriers to cervical cancer screening in Benin, Côte d’Ivoire, Senegal

YOU MAY BE INTERESTED IN

KU Cancer Center deploys new mobile cancer screening bus

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Positive topline results announced from phase I study of Lymphir + pembrolizumab in r/r gynecologic cancers

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

HPV cancer vaccine slows tumor growth, extends survival in animal models

With five-year cancer survival at an all-time high, does this mean people are living longer?

Renew today!

Subscriber content

Never miss an issue!

Login

IARC, Lalla Salma Foundation report addresses barriers to cervical cancer screening in Benin, Côte d’Ivoire, Senegal

YOU MAY BE INTERESTED IN

KU Cancer Center deploys new mobile cancer screening bus

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Positive topline results announced from phase I study of Lymphir + pembrolizumab in r/r gynecologic cancers

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

HPV cancer vaccine slows tumor growth, extends survival in animal models

With five-year cancer survival at an all-time high, does this mean people are living longer?

Never miss an issue!

Login

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”